109 related articles for article (PubMed ID: 16914350)
1. Repeated lipopolysaccharide (LPS) exposure inhibits HIV replication in primary human macrophages.
Equils O; Salehi KK; Cornateanu R; Lu D; Singh S; Whittaker K; Baldwin GC
Microbes Infect; 2006 Aug; 8(9-10):2469-76. PubMed ID: 16914350
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.
Equils O; Schito ML; Karahashi H; Madak Z; Yarali A; Michelsen KS; Sher A; Arditi M
J Immunol; 2003 May; 170(10):5159-64. PubMed ID: 12734363
[TBL] [Abstract][Full Text] [Related]
3. The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice.
Báfica A; Scanga CA; Equils O; Sher A
J Leukoc Biol; 2004 Mar; 75(3):460-6. PubMed ID: 14657211
[TBL] [Abstract][Full Text] [Related]
4. RAW264 macrophages stably transfected with an HIV-1 LTR reporter gene provide a sensitive bioassay for analysis of signalling pathways in macrophages stimulated with lipopolysaccharide, TNF-alpha or taxol.
Sweet MJ; Hume DA
J Inflamm; 1995; 45(2):126-35. PubMed ID: 7583358
[TBL] [Abstract][Full Text] [Related]
5. Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression.
Bernstein MS; Tong-Starksen SE; Locksley RM
J Clin Invest; 1991 Aug; 88(2):540-5. PubMed ID: 1907615
[TBL] [Abstract][Full Text] [Related]
6. Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat.
Equils O; Madak Z; Liu C; Michelsen KS; Bulut Y; Lu D
J Immunol; 2004 Jun; 172(12):7642-6. PubMed ID: 15187145
[TBL] [Abstract][Full Text] [Related]
7. Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4.
Ahmed N; Hayashi T; Hasegawa A; Furukawa H; Okamura N; Chida T; Masuda T; Kannagi M
J Gen Virol; 2010 Nov; 91(Pt 11):2804-13. PubMed ID: 20719993
[TBL] [Abstract][Full Text] [Related]
8. Identification of granulocyte-macrophage colony-stimulating factor and lipopolysaccharide-induced signal transduction pathways that synergize to stimulate HIV type 1 production by monocytes from HIV type 1 transgenic mice.
Osiecki K; Xie L; Zheng JH; Squires R; Pettoello-Mantovani M; Goldstein H
AIDS Res Hum Retroviruses; 2005 Feb; 21(2):125-39. PubMed ID: 15725751
[TBL] [Abstract][Full Text] [Related]
9. Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection.
Victoria S; Temerozo JR; Gobbo L; Pimenta-Inada HK; Bou-Habib DC
Immunobiology; 2013 Dec; 218(12):1529-36. PubMed ID: 23891328
[TBL] [Abstract][Full Text] [Related]
10. Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.
Nordone SK; Ignacio GA; Su L; Sempowski GD; Golenbock DT; Li L; Dean GA
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1387-95. PubMed ID: 18184082
[TBL] [Abstract][Full Text] [Related]
11. Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.
Shattock RJ; Friedland JS; Griffin GE
J Virol; 1993 Jun; 67(6):3569-75. PubMed ID: 7684470
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.
Equils O; Shapiro A; Madak Z; Liu C; Lu D
Antimicrob Agents Chemother; 2004 Oct; 48(10):3905-11. PubMed ID: 15388451
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
Kadoki M; Choi BI; Iwakura Y
Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat.
Zhang Y; Nakata K; Weiden M; Rom WN
J Clin Invest; 1995 May; 95(5):2324-31. PubMed ID: 7738195
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
Herbein G; Montaner LJ; Gordon S
J Virol; 1996 Nov; 70(11):7388-97. PubMed ID: 8892857
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
17. Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA.
Singh A; Palanichamy JK; Ramalingam P; Kassab MA; Bhagat M; Andrabi R; Luthra K; Sinha S; Chattopadhyay P
J Antimicrob Chemother; 2014 Feb; 69(2):404-15. PubMed ID: 24022068
[TBL] [Abstract][Full Text] [Related]
18. LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons.
Simard S; Maurais E; Gilbert C; Tremblay MJ
Clin Immunol; 2008 May; 127(2):198-205. PubMed ID: 18295544
[TBL] [Abstract][Full Text] [Related]
19. Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells.
Shattock RJ; Friedland JS; Griffin GE
J Gen Virol; 1994 Apr; 75 ( Pt 4)():849-56. PubMed ID: 7512119
[TBL] [Abstract][Full Text] [Related]
20. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
